Company: CPMV
Filing Date: 2025-04-15
Form Type: 10-K
Source: 0001683168-25-002584
Chunk: 25

Company: Mosaic ImmunoEngineering Inc.
Filing Date: 2025-04-15
Form: 10-K
Item: Item 1
Chunk 25
---
 undesirable side effects or other
characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective. Currently unknown, drug-related side
effects may be identified in our planned clinical studies and, as such, these possible drug-related side effects could affect patient
recruitment, the ability of enrolled subjects to complete the trial, or result in potential product liability claims. Reported serious
adverse events may arise and the occurrence, whatever the cause, may impact the conduct of any ongoing or future clinical trial. To date,
we have had no product candidates evaluated in any human clinical studies. Any occurrence of clinically significant adverse events may
harm our business, financial condition and prospects significantly.

Our business and operations would suffer in the
event of computer system failures, cyber-attacks or deficiencies in our or third parties’ cyber security.

Given our limited operating history and limited capital,
we are still in the process of implementing our internal security measures. Our internal computer systems and those of current and future
third parties on which we rely may fail and are vulnerable to damage from computer viruses and unauthorized access. Our information technology
and other planned internal infrastructure systems, including corporate firewalls, servers, connection to the Internet, face the risk of
systemic failure that could disrupt our operations. If such an event were to occur and cause interruptions in our operations, it could
result in a material disruption of our development programs and our business operations. To the extent that any disruption or security
breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary
information, we could incur liability, our competitive position could be harmed and the further development and commercialization of product
candidates or any future product candidates could be hindered or delayed. In addition, due to limited corporate infrastructure, our entire
workforce is currently working remotely. This could increase our cyber security risk, create data accessibility concerns, and make us
more susceptible to communication disruptions.

We do not presently maintain insurance coverage to
protect against cybersecurity risks. If we procure such coverage in the future, we cannot ensure that it will be sufficient to cover any
loss we may experience as a result of such cyberattacks. Any cyber incident could have a material adverse effect on our business, financial
condition, and results of operations.

If we fail to establish and maintain proper and
effective internal control over financial reporting, our operating results and our ability to operate our business could be harmed. 

Ensuring that we will have adequate